Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 5

Results: 14

The aurora kinases in cell cycle and leukemia.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 537, doi. 10.1038/onc.2014.14

By:

Goldenson, B;
Crispino, J D

Publication type:

Article

Delaying mitotic exit downregulates FLIP expression and strongly sensitizes tumor cells to TRAIL.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 661, doi. 10.1038/onc.2013.601

By:

Sánchez-Pérez, T;
Medema, R H;
López-Rivas, A

Publication type:

Article

Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 650, doi. 10.1038/onc.2013.584

By:

Satoyoshi, R;
Kuriyama, S;
Aiba, N;
Yashiro, M;
Tanaka, M

Publication type:

Article

Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 639, doi. 10.1038/onc.2013.595

By:

Chudasama, P;
Konrad, A;
Jochmann, R;
Lausen, B;
Holz, P;
Naschberger, E;
Neipel, F;
Britzen-Laurent, N;
Stürzl, M

Publication type:

Article

Alternative lengthening of telomeres in cancer stem cells in vivo.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 611, doi. 10.1038/onc.2013.603

By:

Bojovic, B;
Booth, R E;
Jin, Y;
Zhou, X;
Crowe, D L

Publication type:

Article

Helicobacter pylori might contribute to cancer and/or bone marrow-derived stem cell-related gastrointestinal oncogenesis.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 670, doi. 10.1038/onc.2013.602

By:

Kountouras, J;
Kapetanakis, N;
Zavos, C;
Polyzos, S A;
Romiopoulos, I;
Tsiaousi, E;
Anastasiadou, K;
Giorgakis, N;
Vardaka, E;
Nikolaidou, C;
Venizelos, I;
Katsinelos, P

Publication type:

Article

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 631, doi. 10.1038/onc.2013.587

By:

Pasmant, E;
Gilbert-Dussardier, B;
Petit, A;
de Laval, B;
Luscan, A;
Gruber, A;
Lapillonne, H;
Deswarte, C;
Goussard, P;
Laurendeau, I;
Uzan, B;
Pflumio, F;
Brizard, F;
Vabres, P;
Naguibvena, I;
Fasola, S;
Millot, F;
Porteu, F;
Vidaud, D;
Landman-Parker, J

Publication type:

Article

Opposing role of Notch1 and Notch2 in a Kras<sup>G12D</sup>-driven murine non-small cell lung cancer model.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 578, doi. 10.1038/onc.2013.592

By:

Baumgart, A;
Mazur, P K;
Anton, M;
Rudelius, M;
Schwamborn, K;
Feuchtinger, A;
Behnke, K;
Walch, A;
Braren, R;
Peschel, C;
Duyster, J;
Siveke, J T;
Dechow, T

Publication type:

Article

Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 568, doi. 10.1038/onc.2013.591

By:

Teles Alves, I;
Hartjes, T;
McClellan, E;
Hiltemann, S;
Böttcher, R;
Dits, N;
Temanni, M R;
Janssen, B;
van Workum, W;
van der Spek, P;
Stubbs, A;
de Klein, A;
Eussen, B;
Trapman, J;
Jenster, G

Publication type:

Article

Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 621, doi. 10.1038/onc.2013.580

By:

Teneng, I;
Tellez, C S;
Picchi, M A;
Klinge, D M;
Yingling, C M;
Snider, A M;
Liu, Y;
Belinsky, S A

Publication type:

Article

p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 589, doi. 10.1038/onc.2013.589

By:

Akeno, N;
Miller, A L;
Ma, X;
Wikenheiser-Brokamp, K A

Publication type:

Article

TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 600, doi. 10.1038/onc.2013.593

By:

Zhang, L-H;
Yin, A-A;
Cheng, J-X;
Huang, H-Y;
Li, X-M;
Zhang, Y-Q;
Han, N;
Zhang, X

Publication type:

Article

Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial-mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 546, doi. 10.1038/onc.2013.582

By:

Carpenter, R L;
Paw, I;
Dewhirst, M W;
Lo, H-W

Publication type:

Article

EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 558, doi. 10.1038/onc.2013.590

By:

Miao, H;
Gale, N W;
Guo, H;
Qian, J;
Petty, A;
Kaspar, J;
Murphy, A J;
Valenzuela, D M;
Yancopoulos, G;
Hambardzumyan, D;
Lathia, J D;
Rich, J N;
Lee, J;
Wang, B

Publication type:

Article